MAO (monoamine oxidase) inhibitors are a category of antidepressants that, when applied together with copyright amphetamines like 3-MMC or copyright, may result in a potentially lethal ailment known as “serotonin syndrome.”As a robust stimulant, three-MMC likely carries the highest level of threat when compared with other stimulant medicine, Al